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Condensation: Lactobacillus iners-dominant vaginal microbiomes are more likely to harbor 
vaginal Candida than Lactobacillus crispatus-dominant vaginal microbiomes. 
 
Short Title: Candida and the vaginal microbiome 
 
AJOG at a Glance: 
A. The purpose of the study was to characterize the relationship between the composition of 
the vaginal microbiome and Candida colonization among non-pregnant women.  
B. Women with Lactobacillus iners-dominant microbiomes were more likely to harbor 
Candida than women with Lactobacillus crispatus-dominant microbiomes. In vitro data 
suggests higher production of lactic acid by Lactobacillus crispatus compared to 
Lactobacillus iners may contribute to differential anti-Candida activity. Neutralization of 
pH eliminated the anti-Candida activity secreted by lactobacilli. 
C. Consideration of Candida as part of the vaginal microbiome may have utility for 










Background: The composition of bacteria within the vaginal microbiome has garnered a lot of 
recent attention and has been associated with reproductive health and disease. Despite the 
common occurrence of yeast (primarily Candida) within the vaginal microbiome, there is still an 
incomplete picture of relationships between yeast and bacteria (especially lactobacilli), as well as 
how such associations are governed. Such relationships could be important to a more holistic 
understanding of the vaginal microbiome and its connection to reproductive health. 
Objective: To perform molecular characterization of clinical specimens to define associations 
between vaginal bacteria (especially Lactobacillus species) and Candida colonization. In vitro 
studies were conducted to test the two most common dominant Lactobacillus species 
(Lactobacillus crispatus and Lactobacillus iners) in their ability to inhibit Candida growth and to 
examine the basis for such inhibition. 
Study Design: A nested cross-sectional study of reproductive age women from the 
Contraceptive CHOICE Project was conducted. Vaginal swabs from 299 women were selected 
to balance race and BV status, resulting in similar rep esentation of black and white women in 
each of the three Nugent score categories [normal (0-3), intermediate (4-6), and bacterial 
vaginosis (7-10)]. Sequencing of the 16S ribosomal gene (V4 region) was used to determine the 
dominant Lactobacillus species present (primarily L. iners and L. crispatus), defined as >50% of 
the community. Subjects without dominance by a single Lactobacillus species were classified as 
Diverse. A Candida-specific qPCR targeting the internally transcribed spacer 1 (ITS1) was 
validated using vaginal samples collected from a second cohort of women and used to assess 
Candida colonization. 255 nonpregnant women with sufficient bacterial biomass for analysis 
were included in the final analysis. Generalized linear models were employed to evaluate 








vaginal Candida colonization. In separate in vitro studies, the potential of cell-free supernatants 
from L. crispatus and L. iners cultures to inhibit Candida growth was evaluated. 
Results: Forty-two women (16%) were vaginally colonized with Candida. Microbiomes 
characterized as Diverse (38%), L. iners-dominant (39%), and L. crispatus-dominant (20%) were 
the most common. The microbiome, race and Candida colonization co-varied with a higher 
prevalence of Candida among black women and L. iners-dominant communities compared to 
white women and L. crispatus-dominant communities. L. iners-dominant communities were 
more likely to harbor Candida than L. crispatus-dominant communities (OR = 2.85, 95% CI: 
1.03 to 7.21; Fisher’s Exact, p = 0.048). In vitro, L. crispatus produced greater concentrations of 
lactic acid and exhibited significantly more pH-dependent growth inhibition of C. albicans, 
suggesting a potential mechanism for the clinical observations. 
Conclusion: In nonpregnant women, L. iners-dominant communities were significantly more 
likely to harbor Candida than L. crispatus-dominant communities, suggesting that L ctobacillus 
species have different relationships with Candida. In vitro experiments indicate that L. crispatus 
may impede Candida colonization more effectively than L. iners through a greater production of 
lactic acid. 
 










The human vagina is a dynamic ecosystem that hosts microbes from diverse taxa. Profiling 16S 
ribosomal gene diversity has expanded our understanding of the vaginal microbiome, allowing 
exploration of links between bacterial composition and reproductive outcomes. Vaginal 
microbial communities can be clustered into five common community types.1 Four of these are 
dominated by a single Lactobacillus species: L. crispatus, L. gasseri, L. iners, or L. jensenii. The 
final community type (often described as “Diverse”) has few lactobacilli and exhibits greater 
representation of anaerobic bacteria such as Gardnerella vaginalis, Atopobium vaginae and 
Prevotella spp.1 The prevalence of these community types varies with race and ethnicity; black 
and Hispanic women more frequently host L. iners-dominant and Diverse communities than 
white women, who more frequently host L. crispatus-dominant communities.1,2 Diverse 
communities often harbor bacterial taxa that are abundant during bacterial vaginosis (BV), a 
condition diagnosed by clinical (Amsel) criteria or by Nugent scoring,3 a 0-10 scale generated by 
scoring bacterial morphotypes in Gram-stained vaginal smears (0-3, normal; 4-6, intermediate; 
7-10, BV). BV is associated with increased risks of exually transmitted infections and adverse 
reproductive outcomes.4 
 
Candida (most commonly C. albicans) is a common member of the vaginal microbiome (found 
in ~30% of women5). The prevalence of non-albicans species among women with vaginal 
Candida varies, ranging from ~10-30%.5-9 Vaginal Candida colonization may lead to 
vulvovaginal candidiasis (VVC), characterized by an aggressive host response to Candida 








colonized with Candida go on to experience VVC.5 Vaginal Candida colonization has also been 
linked to other adverse reproductive outcomes.8,11-16 
  
Several prior studies have examined relationships between vaginal bacteria and Candida. A few 
of these studies implicate an abundance of lactobacilli with a greater likelihood of harboring 
Candida.5,6,17 Other studies suggest there may be co-occurrence of Candida with some BV-
associated bacteria,18-21 and specifically that Candida may be correlated with the simultaneous 
presence of both lactobacilli and BV-associated bacteria.19-21 An important limitation is that prior 
studies, whether using molecular or culture-based techniques, have not distinguished between 
lactobacilli at the species level. This is a significant limitation, which if resolved, may shed light 
on why some women are so prone to Candida colonization and candidiasis. 
 
Taken together with the prior studies above, several considerations led us to hypothesize that L. 
iners in particular may support the co-occurrence of Candida, especially compared to L. 
crispatus.  L. iners is unique among the lactobacilli in being prevalent within less stable Nugent 
intermediate and BV communities1,22,23 and in producing a cytolytic toxin.24,25 Furthermore, L. 
iners dominance has been associated with other negative health outcomes such as increased risks 
of Chlamydia trachomatis infection,26 incident BV,27 defects in vaginal mucus that compromise 
antiviral barrier function,28 and cytokine signatures linked with HIV risk.29 We performed two 
types of studies to test our hypothesis that L. iners may preferentially support Candida 












This nested cross-sectional study uses samples and questionnaire data collected by the 
Contraceptive CHOICE Project (CHOICE)30 according to Washington University IRB-approved 
protocol 201108155. In total, 9256 women from the St. Louis-area gave informed consent from 
August 2007 through September 2011. For this nested study, 299 women enrolled from 08/2008-
06/2009 were selected based on power calculations made from preliminary data. Women 
enrolled in the CHOICE study were between the ages of 14 and 45, reported sexual activity in 
the past six months or anticipated sexual activity w h a male partner and were seeking 
contraception. Women with a history of tubal ligation or hysterectomy were excluded. All 
women underwent a pregnancy test. Vaginal swab specimens were self-collected in the vast 
majority of cases , then stored at -80 until analysis. Of the swabs used in the final analysis, one 
was collected by a clinician and the collection method was missing for five samples. 
 
 
Women who completed a baseline survey (including Sociodemographic data) and had a vaginal 
swab available were eligible for inclusion. Samples from all participants underwent Nugent 
scoring to determine BV status.3,31,32 Unfortunately, vaginal pH and data regarding menstrual 
cycle and recent sexual activity was only available for a subset of women and were inadequate 
for analysis. Overall, the distribution of self-reported race/ethnicity of women in the CHOICE 
study were representative of the St. Louis region; few women reported a race other than “black 








other groups, only women who reported “black” or “white” race were eligible for inclusion in 
this sub-study.  
 
Composition of the vaginal microbiota has been previously associated with race.1 To test 
whether Candida was associated with vaginal niches occupied by particular bacterial 
communities, we sought a strategy to avoid inadequat  representation of less common 
community types in the different demographic groups so that we would be powered to ask 
whether Candida is associated with particular microbial patterns. We used frequency matching 
to similarly represent black and white women in each of the three Nugent categories. We used a 
normal:intermediate:BV ratio of 2:2:1 to ensure that we had samples represented across the 
Nugent spectrum, while balancing the practical reality that relatively few BV specimens were 
available from white women. Of the 299 subjects select d, 35 were pregnant at the time of swab 
collection and excluded from final analysis. Additionally, 9 specimens were excluded due to low 
bacterial biomass. See Supplemental Methods.  
 
Microbiome analysis and Candida colonization status: 
DNA was extracted from eluted vaginal swabs and 16S ribosomal profiling of the V4 
hypervariable region was performed as described in the Supplemental Methods. The microbiome 
was classified based on the dominant Lactobacillus species present, defined as 50% relative 
abundance or greater and referred to as, “L. crispatus-, L. iners-, L. gasseri-, or L. jensenii-
dominant” microbiomes. Communities without a single Lactobacillus species reaching 50% 
were referred to as Diverse communities. A pan-C dida qRT-PCR33 that amplifies the 








isolated DNA as template.  Prior to analysis we validated this assay among vaginal specimens 
collected from a second cohort of women enrolled at a different site. See Supplemental Methods 
for details. 
 
Candida growth inhibition: 
Candida strains were grown in yeast extract-peptone-dextrose (YPD) media. C. albicans strain 
SC5314 was obtained from the American Type Culture Collection. Vaginal strains of Candida 
(C. albicans: BAT8133, BAT8135, BAT8143, BAT8152, BAT8154, BAT3353A; C. glabrata: 
BAT8139, BAT3353B) were isolated from women as described in the Supplemental Methods. L. 
crispatus (MV-1A-US, JV-V01, MV-3A-US, 125-2-CHN) and L. iners (UP II 143-D, Lactin 
V09V1-C, LEAF 2032-Ad, LEAF 3008-A) strains were obtained from BEI resources and 
cultured in De Man, Rogosa and Sharpe (MRS) media for 48 hours to make cell free 
supernatants (CFS). All Candida growth inhibition experiments were conducted in 96-well 
plates. Each well contained a 1:1 ratio of CFS and YPD inoculated with ~106 C. albicans colony-
forming units (CFU)/mL. YPD was buffered with 300 mM sodium bicarbonate and 300 mM 
HEPES sodium salt for neutralization assays. For lactic cid growth inhibition assays, fresh MRS 
was supplemented with racemic lactic acid. A micro pH electrode was used to measure pH of 
each mixture and lactate was measured with a colorimet ic assay. Protonated lactic acid 
concentrations were calculated using lactate molarity nd pH using the Henderson-Hasselbalch 











Statistical analyses and data representation were completed in R (v3.5.1) and Prism (v7). Fisher’s 
Exact Tests (Fisher) were used to assess for associtions between cohort characteristics and race, 
with odds ratios (OR) determined by a conditional mxi um likelihood estimate. Unless 
otherwise noted, we used an extension of the generalized linear model (GLM) method that 
included race as a potentially confounding covariate to test for associations between cohort 
characteristics and Candida colonization status, using the exponent of the coeffici nt from the 
logistic regression to calculate ORs. Note that because Candida colonization incidence is >10% 
the odds ratios may not be an accurate approximation of the relative risk; see 34 for conversion 
between the two.  
We used type-II analysis of variance (ANOVA-II) with Wald test and Tukey’s Honestly 
Significant Different Test (Tukey) to evaluate significance in these models. In instances where 
multiple statistical tests were performed, we relied on GLM accounting for race. Mann-Whitney 
tests were used to test for associations with Candida abundance and effect size (r) was calculated 
from the Z value. Statistical tests for in vitro experiments included one-way ANOVA with 
Tukey’s correction for multiple comparisons and Mann-Whitney tests as appropriate. Regardless 
of the statistical method used, P-values < 0.05 were considered significant.  
 
Results 
Description of the clinical cohort: 
Two-hundred fifty-five non-pregnant women of reproductive age were included in our analysis. 
In this cohort, 53% of women identified as “white” and 47% identified as “black”. Forty-four 
(17%) women had BV, while 109 (43%) and 102 (40%) had intermediate and normal vaginal 








trouble meeting daily needs and were classified as having low socioeconomic status. Body mass 
index (BMI) was calculated and categorized using standard methods and definitions. Most 
women (64.3%) reported at least one prior pregnancy. Seventy-two women (28.2%) reported 
vaginal douching in the last 180 days. Race was found to be associated with socioeconomic 
status (p < 0.0001), BMI (p = 0.003), gravidity (p < 0.0001) and vaginal douching (p < 0.0001). 
A summary of demographic data and cohort characteristics by race is presented in Supplemental 
Table 1. 
 
Forty-two (16%) women were vaginally colonized with Candida. Of these, most (90%) were 
colonized by C. albicans. C. glabrata was less common (~10%). Sequencing of the vaginal 
microbiome revealed that fifty-two women (20%) had L. crispatus-dominant microbiomes, 99 
(39%) had L. iners-dominant microbiomes and 98 (38%) had microbiomes that were not 
dominated by a single Lactobacillus species (Diverse). We were not powered to test associations 
between Candida and microbiomes dominated by Lactobacillus jensenii or gasseri since few 
women (n=6) exhibited these microbiomes. Black women w re more likely than white women to 
have L. iners-dominant communities (46.7% vs 31.9% Fisher’s Exact; OR = 1.87, 95% CI: 1.10 
to 3.14, p = 0.020) and less likely to have L. crispatus-dominant communities (11.9% vs. 22.1% 
Fisher’s Exact; OR = 0.380, 95% CI: 0.185 to 0.747, p =  0.003).  
 
Associations between Candida and cohort characteristics: 
 
Forty-two (16%) women were vaginally colonized with Candida. Of these, most (90%) were 








summary of Candida status by sociodemographic and other cohort characteristics. Only race was 
significantly correlated with vaginal Candida; black women were more likely to be colonized 
compared to white women (OR =2.05, 95% CI: 1.03 to 4.25, Fisher’s Exact, p = 0.042). Based 
on these findings, race was considered to be a potential confounder and incorporated into 
subsequent analyses using generalized linear models (GLM) to evaluate factors associated with 
Candida colonization.  
 
Associations between Candida and cohort characteristics 
Candida colonization rates did not differ based on Nugent-defined BV status (GLM; ANOVA-II, 
p = 0.897). We did not find any association between a woman’s socioeconomic status and 
vaginal Candida colonization. Candida colonization did not differ significantly among 
underweight (20% Candida), normal weight (18%) and overweight (23%) women. However, 
obese women were less likely to be colonized compared to non-obese women (GLM; OR = 
0.322, 95% CI: 0.123 to 0.744; Tukey’s HSD, p = 0.013, see Supplement for comment). Women 
reporting current use of hormonal contraceptives containing estrogen and progestin were 
Candida-colonized at higher rates than women reporting non-h rmonal methods, although this 
did not reach statistical significance (GLM; OR = 1.77, 95% CI: 0.858 to 3.58; Tukey’s HSD, p 
= 0.237, see Supplement for details). Women who reprt d vaginal douching in the last 180 days 
were less likely to be Candida positive compared to women who reported no vaginal douching 
(GLM; OR = 0.364, 95% CI: 0.143 to 0.838; Tukey’s HSD, p = 0.047). 
 








Next, we investigated relationships between Ca dida colonization and dominant members of the 
vaginal microbiome based on 16S ribosomal gene profiling. Candida prevalence did not differ 
between Lactobacillus dominated (50% or greater Lactobacillus) and non-Lactobacillus 
dominated microbiomes (GLM; ANOVA-II, p = 0.327).  Although the absolute abundance of 
Candida as measured by qPCR did not differ within L. iners-dominant communities compared to 
other community types (Mann-Whitney, r = 0.046, p =0.617), L. iners-dominant communities 
were more likely to harbor Candida than non-L. iners-dominant communities (GLM; OR = 2.00, 
95% CI: 1.02 to 3.98; Tukey’s HSD, p = 0.045; see supplemental Table 2). Further analysis 
specifically showed that L. iners-dominant communities were more likely to be colonized than L. 
crispatus-dominant communities (OR = 2.85, 95% CI: 1.03 to 7.21; Fisher’s Exact, p = 0.048). 
Among Candida positive women, higher levels of Candida (by qRT-PCR) were observed among 
black women compared to white women, although not statistically significant (Mann-Whitney 
test, r = 0.173, p = 0.131).  
 
In vitro studies: inhibition of Candida growth by lactobacilli: 
Both L. crispatus and lactic acid have been shown to thwart the growth of C. albicans.35-37 Next, 
we compared the inhibitory potential of L. crispatus and L. iners on Candida growth in vitro. C. 
albicans was cultured together with cell free supernatants (CFS) from L. crispatus and L. iners (8 
strains total), followed by Candida CFU enumeration. Compared to L. iners CFS, L. crispatus 
CFS resulted in lower pH (pH = 4.0 vs. pH = 4.6, p < 0.0001) and correspondingly higher levels 
of protonated lactic acid in CFS-YPD (55 mM vs. 11 mM, p < 0.0001) (Figure 2). Buffering 
CFS-YPD to a neutral pH reduced levels of protonated lactic acid to below appreciable levels, 








between L. crispatus and L. iners (Figure 2). Further, lactic acid was sufficient to inhibit 
Candida growth. In particular, significantly more growth inhibition was observed at 49 mM 
protonated lactic acid compared to 11 mM, levels comparable to the L. crispatus and L. iners 
CFS-YPD respectively. Similar findings were seen usi g vaginal isolates of C. albicans. In 
contrast, C. glabrata exhibited only modest growth inhibition (Figure 2). Together, these data 




Principal Findings: We demonstrate that Candida colonization is associated with characteristics 
of the vaginal microbiome (dominance of L. iners compared to L. crispatus). Results in clinical 
specimens are consistent with in vitro data, which show that L. crispatus produces a pH-
dependent factor that inhibits C. albicans growth more effectively compared to secreted factors 
of L. iners grown under the same conditions.  
Results: As a relatively common vaginal microbial community member, Candida may influence 
reproductive health. Previous studies suggested vaginal Lactobacillus colonization as a risk 
factor for Candida colonization or VVC,5,6,17 but seem inconsistent with other reports of 
Candida-bacteria associations.18-21 Here we provide more taxonomic resolution, showing that 
that not all Lactobacillus-dominant communities are equally associated with Candida 
colonization.  
Clinical Implications: Clinicians often group all lactobacilli together. This study adds to the 
growing body of evidence suggesting that L. iners-dominant communities are more permissive to 








Research Implications: Of interest, black race was associated with obesity and vaginal 
douching as in prior studies. But surprisingly, the correlation between Candida and black race 
cannot be accounted for by obesity or douching because obese women and those who douche 
were actually less likely to be colonized with Candida (OR = 0.322 and 0.364 respectively). The 
literature contains inconsistent reports regarding the role of Lactobacillus colonization as a risk 
factor for Candida colonization or VVC.5,6,17,18-21 We show that that not all Lactobacillus-
dominant communities are equally associated with Candida. In vitro data provide one possible 
explanation, showing that L. iners strains do not produce the same magnitude of lactic id 
compared to L. crispatus strains. An alternative, albeit not mutually exclusive explanation, is that 
vaginal Candida colonization may shift the microbiome to favor L. iners.   
Interestingly, we observed similar rates of Candida colonization in L. crispatus-dominant and 
Diverse communities. With fewer lactic acid producing bacteria present, the vaginal pH of 
women with Diverse microbiome is less acidic.1 These findings indicate that Diverse 
communities resist Candida by lactic acid-independent mechanisms.  
Additional studies are needed to evaluate potential mechanisms governing these relationships 
and apply these findings in clinical settings.  
Strengths and Limitations: Key strengths of our study design were the validation of a Candida-
specific qPCR assay33 for laboratory testing for Candida colonization, offering flexibility in 
settings where archived frozen vaginal swabs are mor  practical. We acknowledge that the 
specimens selected for this study are not a naturalistic representation of vaginal microbiomes. 
Rather, the frequency matching of black and white women across the Nugent spectrum is a 
strength that enabled power to test associations between yeast and bacteria in different racial 








relatively small, limiting power to model multiple potential confounders, 2) this cohort may not 
be representative of the U.S. population, 3) clinical data were not available to examine the 
relationship between Candida colonization and VVC, and 4) our in vitro findings may not be 
representative of in vivo relationships.  
Conclusion: These data suggest that L. iners-dominant vaginal communities may support the co-
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Cohort Candida Positive 
Candida 
Negative P-value 
Total Number of Subjects 255 42 (16.5) 213 (83.5)   
Age       0.811 
< 20 28 (11.0) 6 (14.3) 22 (10.3)   
20 to 29 178 (69.8) 29 (69.0) 149 (70.0)   
30 to 39 44 (17.3) 7 (16.7) 37 (17.4)   
40 + 5 (2.0) 0 (0.0) 5 (2.3)   
Race       0.042 
Black 120 (47.1) 26 (61.9) 94 (44.1)   
White 135 (52.9) 16 (38.1) 119 (55.9)   
Nugent-defined Vaginal Flora       0.833 
Normal 102 (40.0) 15 (35.7) 87 (40.8)   
Intermediate 109 (42.7) 19 (45.2) 90 (42.3)   
BV 44 (17.3) 8 (19.0) 36 (16.9)   








Low SES 138 (54.1) 23 (54.8) 115 (54.0)   
Not Low SES 117 (45.9) 19 (45.2) 98 (46.0)   
Body Mass Index (kg/m2)       0.127 
Underweight (< 18.5) 15 (5.9) 3 (7.1) 12 (5.6)   
Normal Weight (18.5 - 24.9) 103 (40.4) 19 (45.2) 84 (39.4)   
Overweight (25 - 30) 48 (18.8) 11 (26.2) 37 (17.4)   
Obese (> 30) 78 (30.6) 7 (16.7) 71 (33.3)   
Not Documented 11 (4.3) 2 (4.8) 9 (4.2)   
Current Birth Control Method       0.320 
Estrogen + Progestina 72 (28.2) 16 (38.1) 56 (26.3)   
Progestinb 12 (4.7) 1(2.4) 11 (5.2)   
Non-Hormonalc 171 (67.1) 25 (59.5) 146 (68.5)   
Vaginal Douching in Last 180 
Days       0.323 
Yes 72 (28.2) 8 (19.0) 64 (30.0)   
No 182 (71.4) 34 (81.0) 148 (69.5)   
Don't Know 1 (0.4) 0 (0.0) 1 (0.5)   
Gravidity       0.160 








1 58 (22.7) 6 (14.3) 52 (24.4)   
2 47 (18.4) 6 (14.3) 41 (19.2)   
3+ 59 (23.1) 15 (35.7) 44 (20.7)   
Community Type       0.113 
L. crispatus-dominant 52 (20.4) 5 (11.9) 47 (22.1)   
L. iners-dominant 99 (38.8) 23 (54.8) 76 (35.7)   
L. jensenii-dominant 3 (1.2) 1 (2.4) 2 (0.9)   
L. gasseri-dominant 3 (1.2) 0 (0.0) 3 (1.4)  
Diverse 98 (38.4) 13 (31.0) 85 (39.9)   
Values are n (%). Fisher’s Exact Tests were used to determine p-values for each set of variables 
without adjusting for race. Note that p-values given in the text use GLM (accounting for race as a 
potential confounder). 
aWomen who reported the oral contraceptive pill or the birth control ring; 
bWomen who reported the l vonorgestrel-containing intrauterine device or 
depot medroxyprogesterone acetate; 
 











Figure 1: Heatmap of all samples in the cohort clustered by community type. 
Heat map of samples clustered by community type showing the top 25 taxa observed across the 
cohort. The bars above the heatmap indicate community type, BV status by Nugent score, race 
and Candida status. In the heat map, light blue indicates the highest abundance, darker blues 
indicate lower abundance and black indicates very low abundance or not present. Black r e (p = 
0.037) and L. iners-dominant communities (p = 0.045) were associated with Candida 
colonization. 
 
Figure 2: In vitro inhibition of Candida by Lactobacillus CFS and lactic acid. 
A-B, Characterization of Candida growth medium supplemented with Lactobacillus CFS (YPD-
CFS) in native and buffered states from four L. crispatus and four L. iners strains, prior to 
Candida inoculation. A, pH of YPD-CFS; B, Concentration of protonated lactic acid in YPD-
CFS; C, Growth inhibition of Candida laboratory strain SC5314, showing three technical 
replicates for each Lactobacillus YPD-CFS. Analysis by one-way ANOVA with Tukey’s 
correction for multiple comparisons.  D-F, Characterization of the inhibitory effect of lactic acid 
supplemented medium on Candida growth. Three technical replicates from two biological 
experiments are shown. D, Growth inhibition of SC5314 by lactic acid showing Mann-Whitney 
test comparison of 11 mM to 49 mM protonated lactic acid; E, Lactic acid growth inhibition of 6 
vaginal C. albicans isolates; F, Lactic acid growth inhibition of 2 vaginal C. glabrata isolates. 
Data points in panel D reflect 6 replicates from two experiments for each condition. Error bars in 








starting inoculum for growth assays is indicated by a dashed line. Statistical significance: ns (not 
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Supplemental Methods 
Coding Survey Data: Data pertaining to age, socioeconomic status (SES), body mass index 
(BMI), current birth control method, vaginal douching and gravidity were extracted from survey 
response data and categorized. Age in years was converted to the following categorical variable: 
less than 20, 20 to 29, 30 to 39, and 40 or more. Low socioeconomic status (Low SES) was 
defined as reporting any current receipt of public assistance (food stamps; Special Supplemental 
Nutrition Program for Women, Infants and Children; welfare; or unemployment) or trouble 
paying for necessities (transportation, housing, health or medical care, or food). BMI (kg/m2) 
was converted to categorical variables as follows: underweight (< 18.5), normal weight (18.5 to 
24.9), overweight (25-30) and obese (>30). Current birth control method was categorized into 
one of three categories: hormonal contraceptives containing a combination of estrogen and 
progestin (Estrogen + Progestin), hormonal contraceptives containing progestin alone 
(Progestin), or non-hormonal contraceptive methods (Non-hormonal).  
Responses indicating the use of oral contraceptive pills or birth control ring were grouped as 
“Estrogen + Progestin”.  Responses indicating the use of a levonorgestrel containing intrauterine 
device or depot medroxyprogesterone acetate were grouped as “Progestin”. Responses indicating 
the use of condoms, rhythm/natural family planning method, abstinence, withdrawal or nothing 
were classified as “Non-hormonal”. The number of times a patient reported vaginal douching in 
the past 180 days was converted to a categorical variable: “yes” if the number was 1 or more, 
“no” if it was 0 and “don’t know” if the patient reported not knowing. Gravidity was converted 
to a categorical variable with “3+” designating a response of 3 or more. 
 
Vaginal Swab Processing and Controls:  
Frozen vaginal swabs (CHOICE study) were arrayed in deep well 96 well plates (Eppendorf, 
Hauppauge, NY) in 1 mL of 0.1 M sodium acetate buffer (pH 5.5). To minimize cross-
contamination during swab elution, each 96 well plate of swabs was arrayed on two plates in a 
checkerboard fashion, such that empty wells were present between samples. Swabs were 
incubated for one hour on ice and agitated every 20 minutes manually. Swabs were removed, and 
the two plates merged by transferring suspensions into a single deep well 96 well plate. The plate 
was then centrifuged at 32,000 x g at 4℃ for 20 minutes and the supernatants removed from the 
samples. The pelleted material was resuspended in 250 microliters of a buffer containing 200 
mM Tris-HCl (pH 8.0), 200 mM NaCl and 20 mM EDTA and then transferred to a 2 mL 
screwcap tube (Axygen, Oneonta, NY) containing 250 μL of (0.1 mm) zirconia/silica beads and 
105 μL of 20% SDS. 250 μL of a solution of phenol:chloroform:isoamyl alcohol (25:24:1) 
saturated with 10 mM Tris (pH 8.0) and 1mM EDTA (Sigma-Aldrich, St. Louis, MO) was 
added. Samples were lysed by mechanical disruption with a bead beater (Biospec Products, 
Bartelsville, OK) for 3 minutes at room temperature before being centrifuged at 32,000 x g at 
4℃ for 5 minutes. DNA was cleaned and concentrated from the aqueous layer using a QIAquick 
96-well PCR Purification Kit (Qiagen, Germantown, MD) with some modifications to the 
manufacturer instructions. The extraction process was automated with an EPMotion that 
performed all pipetting steps. The binding buffer was modified by supplementing 500 mL of 
Buffer PM with 33.3 mL of 3M sodium acetate (pH 5.5). DNA was eluted from the columns 
with 50 μL of water into 96-well PCR plates (Phenix Research Products, Candler, NC). Each 96-
well plate of samples contained the following reagent controls: eight wells of sodium acetate-
eluted sterile swabs and eight wells of sodium acetate buffer used for swab elution. DNA was 
normalized to 5 ng/μL and all samples diluted 1:5 after normalization to dilute PCR inhibitors. 
All PCR plates were sealed with Biomek aluminum foil seals (Becker Coulter, Brea, CA). To 
avoid cross-contamination, plates were centrifuged at 32,000 x g prior to removal of the seal and 
resealed after each use. Also, caution was exercised when using a multichannel pipettor to mix 
samples, microscale splashes and aerosol that could cause cross-contamination were avoided by 
gentle pipetting and expelling material only to the soft stop. 
 
16S Sequencing:  
The V4 hypervariable region was PCR amplified by adding 6.4 μL normalized genomic DNA 
(dilution process described above) to a PCR master mix containing primers with integrated 
barcodes for multiplexing as previously described.38 PCR product was then quantified with a 
Quant-iT dsDNA Assay (Invitrogen, Carlsbad, CA) and pooled into quartiles based on 
abundance prior to size selection by AMPure XP magnetic beads (Beckman Coulter, Pasadena, 
CA). Each purified quartile was then quantified and pooled into a library for 2 x 250 paired-end 
sequencing on an Illumina MiSeq platform through the Center for Genome Science at 
Washington University in St. Louis. 
 
Microbiome Analysis:  
Reads were trimmed to a length of 200 base pairs and mate-pairs merged with a minimum 
overlap of 18 bases. All analysis with Qiime software was completed with version 1.9.0. Reads 
were demultiplexed and OTUs clustered as previously described.38 Taxonomy was assigned to 
OTUs using RDP 2.4 trained on a custom database as previously described.39 Taxa were 
assigned with a confidence of 0.7 or greater. Because the V4 region among some common 
vaginal Lactobacillus species (i.e. Lactobacillus crispatus) share high sequence similarity with 
other Lactobacillus species that rarely colonize the vagina, a modified approach to classifying 
Lactobacillus OTUs to the species level was completed. OTUs assigned to the genus 
Lactobacillus were aligned to the NCBI 16S database using BLASTn. The top ranked species 
returned with a sequence homology of 97% or greater was identified as the OTU species. If the 
top BLASTn hit was less than 97% identical, the OTU was not assigned to the species. Read data 
was then rarefied so that each sample contained 1000 reads.  
 
Inclusion Criteria for Analysis: 
Low bacterial biomass samples are at increased risk of having endogenous signal masked by 
contamination. To avoid the inclusion of low bacterial biomass samples, we used the abundance 
of the V4 amplicon after 16s PCR as a proxy of bacterial biomass. V4 amplicon abundance was 
quantified after 16s PCR and reagent control samples were used to determine the threshold for 
inclusion. The maximum V4 amplicon concentration from all 64 reagent controls quantified was 
chosen as the cutoff for inclusion in analysis (6.1 ng/μL).  We removed 9 samples from analysis 
due to low V4 amplicon abundance. 
 
Candida qPCR Validation: 
A separate cohort was needed to validate the qPCR assay (see below) we later used for determining 
Candida colonization status. Women were recruited from the North Central Community Health 
Center according to Washington University IRB-approved protocol number 201704121. Women 
underwent a speculum exam by a clinician, during which mid-vaginal swabs were collected. Two 
double-headed anaerobic swabs were collected and transported using the Starswab Anaerobic 
Transport System (Starplex Scientific Inc, Cleveland, TN). Two standard aerobic Starplex double 
headed rayon swabs (S09D, Starplex Scientific Inc, Cleveland, TN) were also collected. Anaerobic 
swabs were transported to the laboratory for same day processing and aerobic swabs frozen at -
80℃. Anaerobic swabs were eluted in 2X NYCIII media, and “fresh frozen” (i.e. “0 passage,” 
without growth or amplification of any kind) in the presence of sterile glycerol (20% final). 
Aliquots of fresh frozen material were then stored at -80℃. Fresh frozen aliquots were thawed on 
ice and centrifuged at 3,000 x g for 5 minutes. The media was removed, the pellet resuspended in 
200 μL of YPD, and plated on CHROMagar Candida semi-selective plates (DRG, Springfield, 
NJ). Plates were incubated for 48 hours aerobically at 37℃. Plates were then examined and 
specimens were considered to be culture positive if Candida colonies distinguished by a distinctive 
green color were observed. Specimens that were culture positive for Candida were considered to 
be true positives and this information was used to determine the sensitivity and specificity of the 
Candida (ITS1) qPCR assay described below (conducted on DNA that was isolated from the eluted 
aerobic swab).  
 
Determination of Candida Colonization Status:  
A pan-Candida qPCR33 designed to detect medically relevant Candida species in the presence of 
human genomic DNA, was validated for use on DNA extracted from vaginal swabs as described 
above. The primers 18S-1F (GCAAGTCATCAGCTTGCGTT) and 5.8S-1R 
(TGCGTTCTTCATCGATGCGA) amplify the internally transcribed spacer 1 (ITS1). Power 
SYBR Green PCR Master Mix (Applied Biosystems, Waltham, MA) was used for the qPCR 
reaction and each reaction contained 2 ng of genomic DNA as template. All reactions were run 
in triplicate. CT values were converted to ng of Candida DNA based off a standard curve of 
genomic DNA extracted from C. albicans strain SC5314. A sample was denoted as “Candida 
Positive” if the mean of the replicates was one standard deviation greater than the reported 
detection limit of 10 fg of Candida DNA. Candida DNA quantities were adjusted for initial 
genomic DNA normalization to 5 ng/uL and used as a proxy for Candida abundance. Candida 
species identification was confirmed by Sanger sequencing the ITS1 amplicon and BLASTing 
the sequence against the NCBI database. 
 
Candida Strains: 
The C. albicans strain SC5314 was obtained from the American Type Culture Collection in 
Manassas, VA.   Vaginal Candida strains that were used in the in vitro assays were isolated from 
vaginal swab specimens originally collected from pregnant women as part of a different study, in 
accordance with Washington University IRB-approved protocol number 201610121. Vaginal 
swabs were rolled on CHROMagar Candida plates to isolate Candida colonies and species 
identification was confirmed by sequencing. 
 
Preparation of Lactobacillus Cell Free Supernatant (CFS):  
Four strains of L. crispatus (MV-1A-US, JV-V01, MV-3A-US, 125-2-CHN) and four strains of 
L. iners (UP II 143-D, Lactin V09V1-C, LEAF 2032-Ad, LEAF 3008-A) were cultured to make 
CFS. Lactobacilli were grown in 10 mL of De Man, Rogosa and Sharpe (MRS) media (pH 6.5) 
for 48 hours in 10 mL cell culture flasks (GBO, Monroe, NC) at 37℃ in an anaerobic chamber 
(Coy, Grass Lake, MI). Cultures were centrifuged at 3200 x g for 20 minutes at 4℃ and the 
supernatants filtered through a 0.22 μm filter to remove residual bacteria. CFS was aliquoted in 
microcentrifuge tubes and stored at -20℃. Our findings were reproduced with two different 
batches of CFS from L. crispatus and L. iners. 
 
CFS Growth Inhibition Assays: 
All CFS growth inhibition experiments were conducted in 96-well microplates (GBO, Monroe, 
NC). A mixture of 50 μL Lactobacillus CFS, 40 μL YPD, and 10 μL C. albicans suspension, 
~106 colony-forming units (CFU)/mL, were added to each well. Unconditioned MRS media was 
added instead of Lactobacillus CFS as a control. The plates were sealed with breathable seals 
(Diversified Biotech, Dedham, MA) and incubated aerobically for 16 hours at 37℃ with constant 
shaking at 300 rpm. Suspensions were then plated for CFU on YPD agarose plates. For CFS 
neutralization assay, YPD was buffered to by adding 300 mM sodium bicarbonate and 300 mM 
HEPES resulting in a final pH of 8.6. Lactate concentrations of CFS supplemented YPD medium 
were measured with a colorimetric assay adapted for microplate use (Megazyme, Chicago, IL). 
A micro pH meter (S220-MIC, Mettler-Toledo, Columbus, OH) was used to determine the pH of 
each mixture and the protonated lactic acid concentration calculated using lactate molarity and 
pH using the Henderson-Hasselbalch equation (pKa = 3.9). Each growth inhibition experiment 
was conducted in triplicate and repeated at least twice. 
 
Lactic Acid Inhibition Assays: 
MRS was supplemented with racemic lactic acid (Sigma-Aldrich, St. Louis, MO) at the 
following final concentrations: 100 mM, 200 mM, 300 mM and 400 mM. A mixture of 50 μL 
lactic acid supplemented MRS, 40 μL YPD, and 10 μL Candida suspension (~107 CFU/mL) 
were added to each well. Fresh non-conditioned MRS media was added instead of lactic acid 
supplemented MRS as a control. Suspensions were then plated for CFU on YPD agarose plates. 
Lactate concentrations and pH of lactic acid supplemented YPD medium were measured as 
described above and used to determine the protonated lactic acid concentration. Each growth 




The effect of obesity on the composition of the vaginal microbiome is not well understood. 
Recent studies showed that Nugent score was positively associated with BMI40,41 and obesity has 
also been associated with greater overall diversity and colonization by particular BV-associated 
taxa.42 Previously it was found that obese women were less likely to be heavily colonized with 
Candida.6 Our data support the same conclusion, although using a much more sensitive detection 
method. We found that regardless of race, obese women were more likely to have L.i.-dominant 
than L.c.-dominant communities. Taken together with our finding that L.i.-dominant 
communities were more likely than L.c.-dominant communities to harbor Candida, the data 
suggest a more complex and multifactorial interaction that cannot be explained by the dominant 
species of Lactobacillus present in the vagina. Further study is required to understand the 
interplay between obesity, the microbiome and Candida colonization. Factors that could 
contribute to this interplay may include disturbances in host metabolic, hormonal, and/or 
immune function associated with obesity. A higher prevalence of menstrual irregularity in obese 
women could also contribute to changes in the microbiome. Behaviors could also play a role, for 
example, obese women may be more likely to engage in vaginal douching.40,41 Previous links 
between the gut microbiome and obesity could also be involved, especially given findings that 
the gut microbiome can be a reservoir of vaginal community members,43 including Candida. 
 




Cohort White Race Black Race P-value 
Total Number of Subjects 255 135 (52.9) 120 (47.1)   
Age       0.3073 
< 20 28 (11.0) 12 (8.9) 16 (13.3)   
20 to 29 178 (69.8) 101 (74.8) 77 (64.2)   
30 to 39 44 (17.3) 20 (14.8) 24 (20.0)   
40 + 5 (2.0) 2 (1.5) 3 (2.5)   
Nugent-defined Vaginal Flora       0.420 
BV 44 (17.3) 21 (15.6) 23 (19.2)   
Intermediate 109 (42.7) 55 (40.7) 54 (45.0)   
Normal 102 (40.0) 59 (43.7) 43 (35.8)   
Socioeconomic Status (SES)       < 0.0001 
Not Low SES 117 (45.9) 82 (60.7) 35 (29.2)   
Low SES 138 (54.1) 53 (39.3) 85 (70.8)   
Body Mass Index (kg/m2)       0.003 
Underweight (< 18.5) 15 (5.9) 9 (6.7) 6 (5.0)   
Normal Weight (18.5 - 24.9) 103 (40.4) 68 (50.4) 35 (29.2)   
Overweight (25 - 30) 48 (18.8) 22 (16.3) 26 (21.7)   
Obese (> 30) 78 (30.6) 31 (23.0) 47 (39.2)   
Not Documented 11 (4.3) 5 (3.7) 6 (5.0)   
Current Birth Control Method       0.108 
Estrogen + Progestina  72 (28.2) 42 (31.1) 30 (25.0)   
Progestinb 12 (4.7) 3 (2.2) 9 (7.5)   
Non-Hormonalc 171 (67.1) 90 (66.7) 81 (67.5)   
Vaginal Douching in Last 180 Days       < 0.0001 
Yes 72 (28.2) 17 (12.6) 55 (45.8)   
No 182 (71.4) 117 (86.7) 65 (54.2)   
Don't Know 1 (0.4) 1 (0.7) 0 (0.0)   
Gravidity       < 0.0001 
None 91 (35.7) 64 (47.4) 27 (22.5)   
1 58 (22.7) 28 (20.7) 30 (25.0)   
2 47 (18.4) 25 (18.5) 22 (18.3)   
3 + 59 (23.1) 18 (13.3) 41 (34.2)   
Community Type       0.004 
L. crispatus-dominant 52 (20.4) 37 (27.4) 15 (12.5)   
L. gasseri-dominant 3 (1.2) 1 (0.7) 2 (1.7)   
L. iners-dominant 99 (38.8) 43 (31.9) 56 (46.7)   
Diverse 98 (38.4) 51 (37.8) 47 (39.2)   
L. jensenii-dominant 3 (1.2) 3 (2.2) 0 (0.0)   
Candida       0.042 
Positive 42 (16.5) 16 (11.9) 26 (21.7)   
Negative 213 (83.5) 119 (88.1) 94 (78.3)   
Values are n (%). Fisher’s Exact Tests were used to determine p-values. 
aWomen who reported the oral contraceptive pill or the birth control ring; 
bWomen who reported the levonorgestrel-containing intrauterine device or 
depot medroxyprogesterone acetate; 
 




Supplemental Table 2: Vaginal Candida colonization by race and community type 
 
Characteristics Candida Positive Candida Negative 
Total Number of Subjects 42 (16.5) 213 (83.5) 
Black Race  26 (21.7) 94 (78.3) 
L. crispatus-dominant 2 (13.3) 13 (86.7) 
L. gasseri-dominant 0 (0.0) 2 (100.0) 
L. iners-dominant 17 (30.4) 39 (69.6) 
Diverse 7 (14.9) 40 (85.1) 
L. jensenii-dominant 0 (0.0) 0 (0.0) 
White Race  16 (11.9) 119 (88.1) 
L. crispatus dominant 3 (8.1) 34 (91.9) 
L. gasseri.-dominant 0 (0.0) 1 (100.0) 
L. iners dominant 6 (14.0) 37 (86.0) 
Diverse 6 (11.8) 45 (88.2) 
L. jensenii dominant 1 (33.3) 2 (66.6) 
Values are n (% of characteristic). 
 
Supplemental Figure 1: Validation of Candida qPCR on 51 vaginal swab specimens 
Fifty-one women were assessed for vaginal Candida colonization by culture and qPCR. The mean 
abundance and standard deviation of Candida DNA for each specimen are plotted. Culture positive 
specimens are indicated by the black box. Twelve specimens were culture positive for Candida, 
ten of which were also qPCR positive for Candida. The sensitivity of the qPCR diagnostic was 
83.3% and the specificity was 100% for this set of samples.  
  
Supplemental Figure 1 
 
Sample ID Nugent-defined Vaginal FloraCandida StatusCandida SpeciesNormalized Candida DNA (ng)Race BMI Socioeconomic StatusCommunity TypeCurren Birth Control MethodAge Gravidity Vaginal Douching in Last 180 Days
YES_1 Intermediate Negative 0 Black Overweight Low SES L. iners-dominantNon-hormonal 24 0 No
YES_2 Intermediate Negative 0 White Normal Low SES L. iners-dominantEstrogen + Progestin 23 2 No
YES_3 Normal Negative 0 Black NA Low SES L. crispatus-dominantEstrogen + Progestin 24 0 Yes
YES_4 Normal Negative 0 Black Normal Low SES L. crispatus-dominantNon-hormonal 30 2 No
YES_5 BV Negative 65.0969761 Black Normal Low SES Diverse Non-hormonal 20 0 Yes
YES_6 Intermediate Negative 0 Black Obese Low SES L. iners-dominantNon-hormonal 19 0 No
YES_7 BV Positive Candida albicans86570.0454 Black Normal Not Low SES Diverse Non-hormonal 23 3 No
YES_8 Intermediate Negative 0 White Underweight Not Low SES L. crispatus-dominantNon-hormonal 21 3 No
YES_9 BV Negative 1.44113294 White Normal Not Low SES Diverse Non-hormonal 21 2 No
YES_10 Normal Negative 0 White Obese Not Low SES L. gasseri-dominantNon-hormonal 32 2 No
YES_11 BV Positive Candida albicans8253.5563 Black Normal Not Low SES Diverse Estrogen + Progestin 23 1 No
YES_12 BV Negative 116.041788 White Obese Low SES Diverse Non-hormonal 19 1 No
YES_13 Intermediate Negative 0 White Normal Not Low SES L. crispatus-dominantNon-hormonal 21 0 No
YES_14 Intermediate Negative 0 Black Obese Low SES L. iners-dominantEstrogen + Progestin 22 1 No
YES_15 Normal Negative 0 White Normal Low SES L. crispatus-dominantNon-hormonal 20 0 No
YES_16 BV Negative 6.10425286 Black Obese Low SES Diverse Non-hormonal 18 0 No
YES_17 Intermediate Negative 0 White Obese Low SES L. iners-dominantNon-hormonal 20 0 No
YES_18 BV Negative 8.013427 Black Overweight Low SES Diverse Non-hormonal 21 2 Yes
YES_19 BV Negative 57.7992007 White Underweight Low SES L. iners-dominantNon-hormonal 22 1 No
YES_20 Normal Negative 0 Black Overweight Low SES L. crispatus-dominantNon-hormonal 24 1 No
YES_21 Intermediate Positive Candida glabrata1894.93576 White Obese Low SES L. iners-dominantNon-hormonal 34 3 No
YES_22 Normal Negative 0 White Obese Low SES L. iners-dominantNon-hormonal 21 0 No
YES_23 Intermediate Positive Candida albicans187463.887 Black Overweight Not Low SES L. iners-dominantEstrogen + Progestin 26 1 No
YES_24 Normal Positive Candida albicans1481.17532 White Normal Not Low SES L. iners-dominantEstrogen + Progestin 23 0 No
YES_25 BV Negative 58.2963389 White Obese Not Low SES Diverse Non-hormonal 20 1 Yes
YES_26 Intermediate Positive Candida albicans208.050562 White Normal Not Low SES Diverse Non-hormonal 21 0 No
YES_27 Intermediate Negative 0 White Normal Not Low SES L. iners-dominantNon-hormonal 18 0 No
YES_28 Intermediate Negative 0 Black Normal Low SES L. iners-dominantNon-hormonal 27 1 Yes
YES_29 Normal Positive Candida albicans28412.1258 Black Overweight Not Low SES L. crispatus-dominantNon-hormonal 25 3 No
YES_30 Intermediate Negative 0 Black Overweight Low SES Diverse Estrogen + Progestin 20 1 Yes
YES_31 Normal Negative 0 Black Normal Low SES L. crispatus-dominantEstrogen + Progestin 24 1 No
YES_32 Normal Negative 0 White Normal Not Low SES L. crispatus-dominantNon-hormonal 23 0 No
YES_33 BV Negative 0.25993252 Black Obese Low SES Diverse Non-hormonal 23 3 Yes
YES_34 Normal Negative 0 White Normal Not Low SES L. crispatus-dominantEstrogen + Progestin 22 0 No
YES_35 BV Negative 0 White Normal Not Low SES Diverse Estrogen + Progestin 23 0 No
YES_36 BV Negative 0 White Normal Low SES Diverse Non-hormonal 29 3 Yes
YES_37 BV Negative 0 White Normal Low SES Diverse Non-hormonal 19 3 No
YES_38 BV Positive Candida glabrata29032.683 White Normal Not Low SES Diverse Estrogen + Progestin 26 0 No
YES_41 BV Negative 0 Black NA Not Low SES Diverse Non-hormonal 20 1 No
YES_42 Intermediate Negative 0 White Normal Not Low SES L. iners-dominantNon-hormonal 23 0 No
YES_43 Normal Negative 0 White Normal Not Low SES L. crispatus-dominantNon-hormonal 19 0 No
YES_44 Intermediate Negative 8.1113445 White Normal Not Low SES L. iners-dominantNon-hormonal 25 0 No
YES_45 Intermediate Negative 0 White Obese Not Low SES Diverse Estrogen + Progestin 19 1 No
YES_46 Intermediate Negative 0 Black Obese Not Low SES L. iners-dominantEstrogen + Progestin 18 0 Yes
YES_47 Normal Negative 0 Black Obese Not Low SES L. crispatus-dominantEstrogen + Progestin 40 1 Yes
YES_48 BV Negative 0 Black Obese Low SES Diverse Estrogen + Progestin 24 2 Yes
YES_49 Intermediate Negative 0 White Normal Not Low SES Diverse Non-hormonal 43 3 No
YES_50 BV Positive Candida albicans63.0981781 Black Obese Low SES Diverse Non-hormonal 21 3 No
YES_51 BV Positive Candida albicans2438.76092 Black Normal Low SES Diverse Estrogen + Progestin 21 3 No
YES_52 Normal Negative 0 White Overweight Not Low SES L. crispatus-dominantEstrogen + Progestin 23 0 No
YES_53 Normal Negative 0 White Normal Not Low SES L. crispatus-dominantEstrogen + Progestin 24 0 No
YES_54 Intermediate Negative 13.7641916 Black Obese Low SES L. iners-dominantEstrogen + Progestin 22 3 Yes
YES_55 Intermediate Negative 0 White Normal Low SES L. iners-dominantProgestin 33 2 Yes
YES_56 Normal Negative 0 White Normal Not Low SES L. crispatus-dominantEstrogen + Progestin 20 0 No
YES_57 Normal Negative 5.70184789 White Obese Low SES L. crispatus-dominantNon-hormonal 22 1 No
YES_58 Intermediate Negative 0 White Overweight Not Low SES L. iners-dominantNon-hormonal 33 2 No
YES_59 Intermediate Negative 0 White Overweight Low SES L. iners-dominantNon-hormonal 19 1 No
YES_60 Intermediate Negative 0 White Overweight Not Low SES L. iners-dominantNon-hormonal 38 3 No
YES_61 Normal Negative 0 White Normal Not Low SES L. iners-dominantNon-hormonal 33 1 No
YES_62 Intermediate Negative 0 White Underweight Not Low SES L. iners-dominantNon-hormonal 21 0 No
YES_63 Normal Negative 0 Black Obese Low SES L. iners-dominantNon-hormonal 35 1 Yes
YES_64 Intermediate Negative 8.2100207 Black Obese Low SES L. iners-dominantNon-hormonal 22 1 Yes
YES_65 Normal Negative 0 White Obese Not Low SES L. iners-dominantProgestin 37 3 No
YES_66 Intermediate Negative 0 White Normal Low SES L. iners-dominantEstrogen + Progestin 22 0 No
YES_67 Normal Negative 0 White Obese Not Low SES L. iners-dominantEstrogen + Progestin 20 1 No
YES_68 BV Negative 0 Black Normal Low SES Diverse Non-hormonal 22 1 No
YES_69 Intermediate Negative 2.6648135 White Normal Not Low SES Diverse Non-hormonal 25 2 No
YES_70 BV Negative 0 White Normal Low SES Diverse Non-hormonal 30 2 No
YES_71 Normal Negative 0 White Obese Not Low SES L. crispatus-dominantNon-hormonal 20 0 No
YES_72 Normal Negative 2.2703877 White Normal Not Low SES L. crispatus-dominantEstrogen + Progestin 25 0 No
YES_73 Normal Negative 0 White Normal Not Low SES L. iners-dominantEstrogen + Progestin 24 2 Yes
YES_74 Normal Negative 0 White Normal Low SES L. iners-dominantEstrogen + Progestin 28 1 No
YES_75 BV Negative 2.96112474 White Normal Low SES Diverse Non-hormonal 28 3 Yes
YES_76 Normal Negative 0 White Normal Not Low SES Diverse Estrogen + Progestin 30 2 No
YES_77 Intermediate Negative 0 Black Underweight Low SES Diverse Non-hormonal 24 3 Yes
YES_78 Intermediate Negative 0 White Normal Not Low SES L. iners-dominantNon-hormonal 23 1 No
YES_79 Intermediate Negative 0 Black Overweight Not Low SES Diverse Non-hormonal 23 2 No
YES_82 BV Negative 0 White Normal Low SES Diverse Non-hormonal 24 0 No
YES_83 BV Negative 2.65649706 White Normal Not Low SES Diverse Non-hormonal 22 1 Yes
YES_84 Normal Negative 0.79815645 White Normal Low SES L. crispatus-dominantNon-hormonal 26 2 No
YES_85 Normal Positive Candida albicans328.284827 White Normal Not Low SES L. crispatus-dominantEstrogen + Progestin 24 0 No
YES_86 Intermediate Negative 0 Black NA Not Low SES Diverse Non-hormonal 21 0 No
YES_87 Normal Negative 0 White Normal Not Low SES L. iners-dominantNon-hormonal 18 1 No
YES_88 Intermediate Negative 0 White Obese Low SES L. iners-dominantNon-hormonal 23 0 No
YES_89 BV Positive Candida albicans7023.12315 White Overweight Not Low SES Diverse Non-hormonal 23 0 No
YES_90 Normal Negative 23451.8114 White Obese Not Low SES L. iners-dominantEstrogen + Progestin 24 0 No
YES_91 Intermediate Negative 0 White Normal Not Low SES L. iners-dominantNon-hormonal 19 0 No
YES_92 Normal Negative 0 White Normal Low SES L. crispatus-dominantNon-hormonal 25 3 Yes
YES_93 Intermediate Negative 2.70333166 White Normal Low SES Diverse Estrogen + Progestin 21 1 Yes
YES_94 Intermediate Negative 0 White Normal Low SES Diverse Non-hormonal 38 3 No
YES_95 Normal Negative 0.81906327 Black Obese Not Low SES L. iners-dominantEstrogen + Progestin 19 0 No
YES_96 Normal Negative 0 White Obese Not Low SES L. crispatus-dominantEstrogen + Progestin 31 1 Yes
YES_97 Intermediate Negative 0 Black Overweight Not Low SES Diverse Estrogen + Progestin 31 3 No
YES_98 Intermediate Negative 0 Black Normal Low SES L. iners-dominantNon-hormonal 25 1 No
YES_99 BV Negative 0 White Obese Low SES Diverse Non-hormonal 21 0 No
YES_100 Intermediate Negative 1.79653156 Black NA Low SES L. iners-dominantNon-hormonal 23 3 Yes
YES_101 Normal Negative 10.5067974 White Normal Low SES L. iners-dominantNon-hormonal 21 0 No
YES_102 Normal Negative 0 White Overweight Not Low SES L. crispatus-dominantEstrogen + Progestin 25 1 No
YES_103 Normal Positive Candida albicans12340.7547 White Normal Not Low SES L. crispatus-dominantNon-hormonal 21 0 No
YES_104 Intermediate Positive Candida albicans24436.127 Black Obese Low SES L. iners-dominantNon-hormonal 29 3 Yes
YES_105 BV Positive Candida albicans1499.42015 Black Underweight Low SES L. iners-dominantNon-hormonal 17 1 No
YES_106 Normal Negative 42.2505624 White Normal Not Low SES L. crispatus-dominantNon-hormonal 24 0 No
YES_107 Intermediate Positive Candida albicans38623.9263 Black Overweight Low SES L. iners-dominantEstrogen + Progestin 25 3 No
YES_108 Intermediate Negative 0 Black Obese Low SES L. iners-dominantNon-hormonal 24 0 No
YES_109 BV Negative 162.516486 Black Obese Low SES Diverse Non-hormonal 21 1 No
YES_110 Intermediate Positive Candida albicans9540.73006 Black Overweight Low SES L. iners-dominantNon-hormonal 36 3 No
YES_111 Normal Negative 0 White Overweight Not Low SES L. crispatus-dominantNon-hormonal 25 0 No
YES_112 Normal Negative 0 Black Obese Low SES L. iners-dominantNon-hormonal 34 3 No
YES_113 Normal Negative 0 White Normal Not Low SES L. crispatus-dominantNon-hormonal 24 0 No
YES_114 BV Negative 0 Black Obese Low SES Diverse Estrogen + Progestin 20 0 Yes
YES_115 Intermediate Negative 0 White Normal Not Low SES Diverse Non-hormonal 24 0 No
YES_116 Intermediate Negative 9.02890426 White NA Low SES Diverse Non-hormonal 28 3 Yes
YES_117 Intermediate Positive Candida albicans42.1348947 Black Underweight Not Low SES L. iners-dominantNon-hormonal 19 2 Yes
YES_118 BV Negative 0 White Normal Low SES Diverse Non-hormonal 37 2 No
YES_119 Intermediate Negative 1.28036551 White Overweight Not Low SES Diverse Progestin 17 0 No
YES_120 Intermediate Negative 0 Black Normal Low SES L. iners-dominantProgestin 22 1 No
YES_123 BV Negative 0 Black Overweight Low SES Diverse Non-hormonal 29 3 Yes
YES_124 Intermediate Negative 2.71624999 White Overweight Not Low SES Diverse Non-hormonal 24 1 No
YES_125 Normal Negative 0 Black Normal Not Low SES L. crispatus-dominantNon-hormonal 19 0 No
YES_126 Intermediate Negative 26.4265269 Black Normal Not Low SES Diverse Non-hormonal 24 0 Yes
YES_127 Intermediate Negative 0 Black Obese Low SES Diverse Non-hormonal 20 2 No
YES_128 Intermediate Negative 0 White Obese Not Low SES L. crispatus-dominantNon-hormonal 24 0 No
YES_129 Intermediate Negative 0.39771533 Black Overweight Not Low SES L. crispatus-dominantEstrogen + Progestin 19 0 No
YES_130 Intermediate Negative 0 White Normal Not Low SES L. crispatus-dominantNon-hormonal 25 1 No
YES_131 Intermediate Negative 0 White Obese Low SES Diverse Non-hormonal 34 2 No
YES_132 Intermediate Negative 0 White Normal Not Low SES Diverse Non-hormonal 20 1 No
YES_133 Normal Negative 0 Black Normal Low SES L. iners-dominantNon-hormonal 26 3 Yes
YES_134 Intermediate Negative 0 White Overweight Not Low SES Diverse Estrogen + Progestin 21 1 No
YES_135 Normal Positive Candida albicans4134.34169 White Normal Not Low SES L. crispatus-dominantEstrogen + Progestin 21 0 No
YES_136 Normal Negative 0 White Overweight Not Low SES L. iners-dominantEstrogen + Progestin 27 2 No
YES_137 Intermediate Negative 0 Black Obese Low SES L. iners-dominantNon-hormonal 24 3 No
YES_138 Normal Negative 0 Black Obese Not Low SES L. iners-dominantEstrogen + Progestin 39 3 No
YES_139 Normal Negative 11.8700646 Black Obese Not Low SES L. crispatus-dominantNon-hormonal 26 3 Yes
YES_140 Normal Negative 0 Black Normal Low SES L. crispatus-dominantNon-hormonal 19 0 Yes
YES_141 Normal Negative 0 Black Obese Not Low SES L. gasseri-dominantNon-hormonal 28 3 No
YES_142 Normal Negative 0 Black Obese Low SES L. iners-dominantNon-hormonal 27 3 Yes
YES_143 Normal Negative 0 Black Underweight Not Low SES L. iners-dominantEstrogen + Progestin 29 1 No
YES_144 Normal Negative 0 Black Normal Low SES L. iners-dominantEstrogen + Progestin 21 2 No
YES_145 Intermediate Negative 0.25398265 Black Overweight Low SES Diverse Non-hormonal 22 3 Yes
YES_146 Normal Negative 0 White Underweight Low SES L. crispatus-dominantNon-hormonal 22 0 No
YES_147 Intermediate Negative 0 Black Normal Not Low SES Diverse Estrogen + Progestin 20 1 No
YES_148 Intermediate Negative 0 White Overweight Low SES Diverse Non-hormonal 20 1 No
YES_149 Normal Negative 0 White Normal Low SES L. iners-dominantNon-hormonal 26 2 No
YES_150 Normal Negative 23.4111701 Black Overweight Low SES L. crispatus-dominantNon-hormonal 29 2 No
YES_151 Intermediate Negative 69.6541605 White Obese Not Low SES L. crispatus-dominantNon-hormonal 25 1 No
YES_152 Normal Positive Candida albicans568.299559 Black Normal Low SES L. iners-dominantEstrogen + Progestin 26 0 No
YES_153 BV Negative 1.61002131 Black Normal Low SES Diverse Progestin 18 0 Yes
YES_154 Intermediate Negative 0 White Normal Not Low SES L. jensenii-dominantNon-hormonal 18 0 No
YES_155 Intermediate Negative 0 White Underweight Low SES L. iners-dominantEstrogen + Progestin 20 2 No
YES_156 Normal Negative 0 Black Normal Not Low SES L. iners-dominantNon-hormonal 23 0 No
YES_157 Normal Negative 2.1838732 White Normal Not Low SES L. crispatus-dominantEstrogen + Progestin 26 0 No
YES_158 Normal Negative 0 White Overweight Not Low SES L. crispatus-dominantEstrogen + Progestin 22 0 No
YES_159 Intermediate Negative 0 White Normal Not Low SES Diverse Non-hormonal 20 1 Yes
YES_160 Intermediate Negative 12.133129 White Obese Low SES Diverse Non-hormonal 20 0 No
YES_161 Normal Negative 0 Black Obese Low SES L. iners-dominantNon-hormonal 20 2 No
YES_164 Normal Negative 0 White Normal Not Low SES L. iners-dominantNon-hormonal 21 0 No
YES_165 Intermediate Positive Candida albicans47.6500989 White Obese Not Low SES L. iners-dominantEstrogen + Progestin 23 0 No
YES_166 Intermediate Negative 4.99994678 Black Overweight Low SES L. iners-dominantNon-hormonal 21 2 No
YES_167 Normal Negative 0 White Normal Low SES L. iners-dominantNon-hormonal 20 0 No
YES_168 Normal Negative 0 White Obese Low SES L. crispatus-dominantNon-hormonal 44 2 No
YES_169 Normal Negative 0 White Overweight Not Low SES L. iners-dominantEstrogen + Progestin 20 0 No
YES_170 Normal Negative 0 White Normal Not Low SES L. iners-dominantEstrogen + Progestin 23 1 No
YES_171 Normal Negative 0 Black Normal Low SES Diverse Non-hormonal 26 3 Yes
YES_172 Normal Negative 1.15549064 White Underweight Not Low SES L. crispatus-dominantNon-hormonal 22 0 No
YES_173 Normal Negative 0 White Underweight Not Low SES L. crispatus-dominantNon-hormonal 25 0 No
YES_174 Normal Negative 0 White Normal Not Low SES L. crispatus-dominantEstrogen + Progestin 23 0 No
YES_175 Intermediate Positive Candida albicans713.767451 White Normal Low SES Diverse Estrogen + Progestin 23 2 No
YES_176 Intermediate Negative 0 White Normal Not Low SES Diverse Estrogen + Progestin 21 1 No
YES_177 Intermediate Negative 0 White Obese Low SES L. iners-dominantNon-hormonal 26 2 No
YES_178 Intermediate Negative 0 White Obese Not Low SES L. iners-dominantNon-hormonal 24 0 No
YES_179 Intermediate Positive Candida albicans563.647457 Black Normal Low SES L. iners-dominantNon-hormonal 19 0 No
YES_180 Intermediate Positive Candida glabrata3342.61464 White Normal Not Low SES Diverse Non-hormonal 25 3 Yes
YES_181 Intermediate Negative 0.95358647 White Normal Low SES Diverse Non-hormonal 26 2 Yes
YES_182 Intermediate Negative 0 Black Obese Low SES Diverse Non-hormonal 26 1 Yes
YES_183 Normal Negative 0 White Normal Not Low SES L. jensenii-dominantNon-hormonal 22 0 Yes
YES_184 Normal Negative 0 White Overweight Low SES L. crispatus-dominantNon-hormonal 27 2 No
YES_185 BV Negative 6.4605685 White Obese Not Low SES Diverse Estrogen + Progestin 24 1 No
YES_186 BV Negative 1.5078887 White Overweight Low SES Diverse Non-hormonal 18 1 No
YES_187 Intermediate Negative 0 Black Overweight Low SES Diverse Progestin 38 3 No
YES_188 Intermediate Negative 0 White NA Not Low SES Diverse Non-hormonal 25 0 No
YES_189 Intermediate Negative 0 White Normal Not Low SES Diverse Estrogen + Progestin 37 3 Unknown
YES_190 Intermediate Negative 0.57756761 Black Normal Not Low SES L. iners-dominantNon-hormonal 17 0 No
YES_191 Intermediate Negative 0 Black Obese Not Low SES Diverse Non-hormonal 24 1 Yes
YES_192 Intermediate Negative 14.506964 Black Obese Not Low SES Diverse Non-hormonal 32 2 Yes
YES_193 Normal Positive Candida albicans173082.034 Black Obese Low SES L. crispatus-dominantEstrogen + Progestin 29 1 Yes
YES_194 Intermediate Negative 6.52451099 Black Normal Not Low SES L. gasseri-dominantNon-hormonal 31 1 No
YES_195 Normal Positive Candida albicans1099.04235 Black Normal Low SES L. iners-dominantEstrogen + Progestin 32 3 No
YES_196 Intermediate Negative 1.10024304 White Normal Not Low SES Diverse Non-hormonal 39 2 No
YES_197 Intermediate Negative 5.52333002 White Normal Low SES Diverse Non-hormonal 26 0 Yes
YES_198 BV Negative 12.3443957 White NA Low SES Diverse Non-hormonal 26 2 No
YES_199 Intermediate Negative 0 Black Overweight Not Low SES Diverse Estrogen + Progestin 31 2 Yes
YES_200 Intermediate Negative 0 White Overweight Not Low SES Diverse Non-hormonal 22 0 No
YES_201 Intermediate Positive Candida albicans3775.30361 Black Normal Low SES L. iners-dominantNon-hormonal 23 1 No
YES_202 Normal Negative 4.56336091 White Overweight Low SES L. crispatus-dominantEstrogen + Progestin 23 0 No
YES_205 Normal Positive Candida albicans42294.0128 White NA Not Low SES L. iners-dominantNon-hormonal 23 0 No
YES_206 Normal Positive Candida albicans62174.0822 Black Overweight Low SES L. iners-dominantNon-hormonal 31 2 No
YES_207 Intermediate Negative 1.40141557 Black Obese Not Low SES L. iners-dominantNon-hormonal 20 0 Yes
YES_208 Normal Negative 0 White Normal Not Low SES L. iners-dominantEstrogen + Progestin 23 0 No
YES_209 Normal Negative 6.47304481 White NA Low SES Diverse Non-hormonal 31 3 No
YES_210 Intermediate Positive Candida albicans806.516955 White Overweight Low SES L. jensenii-dominantNon-hormonal 21 0 No
YES_211 Normal Negative 2.62901394 White Normal Low SES L. crispatus-dominantNon-hormonal 34 3 No
YES_212 Normal Negative 1.18513934 Black Overweight Not Low SES L. iners-dominantProgestin 30 1 No
YES_213 Normal Positive Candida albicans706.047377 White Normal Low SES L. iners-dominantNon-hormonal 23 2 No
YES_214 BV Negative 0 Black Obese Low SES Diverse Non-hormonal 32 3 Yes
YES_215 Normal Negative 0 White Normal Low SES L. iners-dominantNon-hormonal 21 3 No
YES_216 BV Negative 0 Black Obese Low SES Diverse Non-hormonal 33 2 Yes
YES_217 Normal Negative 1.70115654 Black Normal Not Low SES L. iners-dominantEstrogen + Progestin 31 3 No
YES_218 Intermediate Positive Candida albicans143133.167 White Underweight Not Low SES L. iners-dominantNon-hormonal 19 0 No
YES_219 Normal Negative 0 White Overweight Low SES L. crispatus-dominantEstrogen + Progestin 34 3 No
YES_220 BV Negative 0 Black Normal Low SES Diverse Non-hormonal 32 3 No
YES_221 Intermediate Positive Candida albicans707.844725 White Overweight Not Low SES Diverse Estrogen + Progestin 22 0 No
YES_222 Normal Negative 0 Black Obese Low SES L. crispatus-dominantProgestin 26 1 Yes
YES_223 Intermediate Negative 0 Black Overweight Not Low SES Diverse Non-hormonal 20 1 Yes
YES_224 Intermediate Negative 0 Black Overweight Low SES L. iners-dominantEstrogen + Progestin 27 3 No
YES_225 BV Negative 0 White Obese Not Low SES Diverse Non-hormonal 21 0 Yes
YES_226 Normal Positive Candida glabrata726.484911 Black NA Low SES L. iners-dominantProgestin 18 2 No
YES_227 Normal Negative 0 Black Overweight Low SES L. crispatus-dominantNon-hormonal 28 3 Yes
YES_228 Intermediate Negative 3.87273945 Black Normal Low SES Diverse Non-hormonal 23 2 No
YES_229 Intermediate Positive Candida albicans447096.875 Black Overweight Not Low SES Diverse Non-hormonal 22 3 No
YES_230 Normal Negative 0 White Obese Low SES Diverse Non-hormonal 22 1 No
YES_231 Normal Negative 0 Black Obese Low SES L. iners-dominantProgestin 32 2 Yes
YES_232 BV Negative 0 Black Obese Not Low SES Diverse Non-hormonal 28 0 Yes
YES_233 Normal Negative 0 White Underweight Low SES L. crispatus-dominantNon-hormonal 24 1 No
YES_234 Normal Negative 0 Black Underweight Low SES L. iners-dominantNon-hormonal 25 3 Yes
YES_235 Normal Positive Candida albicans7528.63518 Black Overweight Low SES L. iners-dominantEstrogen + Progestin 29 1 Yes
YES_236 Intermediate Negative 5.86670172 Black Obese Low SES Diverse Non-hormonal 29 2 No
YES_237 Intermediate Negative 3.62933363 Black Normal Low SES Diverse Non-hormonal 21 1 No
YES_238 Intermediate Negative 0 Black Obese Low SES L. iners-dominantNon-hormonal 23 0 Yes
YES_239 Intermediate Positive Candida albicans3332.48181 Black Normal Low SES Diverse Estrogen + Progestin 36 3 Yes
YES_240 Intermediate Negative 0 Black Obese Low SES Diverse Progestin 44 2 Yes
YES_241 Intermediate Negative 0.84273838 Black Obese Low SES Diverse Non-hormonal 20 0 Yes
YES_242 Intermediate Negative 0.44740179 Black Obese Low SES L. iners-dominantNon-hormonal 22 3 Yes
YES_243 Intermediate Positive Candida albicans512142.994 Black Overweight Low SES L. iners-dominantNon-hormonal 32 3 No
YES_246 Intermediate Negative 2.46120436 Black Obese Low SES Diverse Non-hormonal 17 0 No
YES_247 Normal Positive Candida albicans1048.67416 Black Normal Low SES L. iners-dominantNon-hormonal 31 3 Yes
YES_248 BV Negative 0.51121459 White Obese Low SES Diverse Estrogen + Progestin 32 0 No
YES_249 BV Negative 0 White Obese Not Low SES Diverse Non-hormonal 25 0 No
YES_250 Normal Negative 0 Black Obese Low SES L. iners-dominantEstrogen + Progestin 41 3 Yes
YES_251 Normal Negative 5.25077639 Black Normal Low SES L. iners-dominantEstrogen + Progestin 26 0 Yes
YES_252 Normal Negative 0.66421679 Black Obese Low SES L. iners-dominantNon-hormonal 20 0 Yes
YES_253 Normal Negative 0 Black Underweight Not Low SES L. crispatus-dominantNon-hormonal 19 2 Yes
YES_254 Normal Negative 181.228631 Black Obese Low SES L. iners-dominantNon-hormonal 37 3 No
YES_255 Normal Negative 5.38271329 Black Obese Low SES L. iners-dominantNon-hormonal 21 1 Yes
